PIK3CA and breast cancer: For cross-species comparison of pathway-level mutations and SCNAs between CMT and human breast cancer, we examined 13 genes belonging to two signaling pathways (the PI3K-Akt and p53 pathways), particularly in regards to the frequencies of activation or inactivation thereof in benign and malignant CMTs and in human breast cancer (Fig. 4a).